Literature DB >> 26214263

POZylation: a new approach to enhance nanoparticle diffusion through mucosal barriers.

Edward D H Mansfield1, Katy Sillence, Patrick Hole, Adrian C Williams, Vitaliy V Khutoryanskiy.   

Abstract

The increasing use of nanoparticles in the pharmaceutical industry is generating concomitant interest in developing nanomaterials that can rapidly penetrate into, and permeate through, biological membranes to facilitate drug delivery and improve the bioavailability of active pharmaceutical ingredients. Here, we demonstrate that the permeation of thiolated silica nanoparticles through porcine gastric mucosa can be significantly enhanced by their functionalization with either 5 kDa poly(2-ethyl-2-oxazoline) or poly(ethylene glycol). Nanoparticle diffusion was assessed using two independent techniques; Nanoparticle Tracking Analysis, and fluorescence microscopy. Our results show that poly(2-ethyl-2-oxazoline) and poly(ethylene glycol) have comparable abilities to enhance diffusion of silica nanoparticles in mucin dispersions and through the gastric mucosa. These findings provide a new strategy in the design of nanomedicines, by surface modification or nanoparticle core construction, for enhanced transmucosal drug delivery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26214263     DOI: 10.1039/c5nr03178h

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  6 in total

Review 1.  Design strategies for physical-stimuli-responsive programmable nanotherapeutics.

Authors:  Fitsum Feleke Sahle; Muhammad Gulfam; Tao L Lowe
Journal:  Drug Discov Today       Date:  2018-04-10       Impact factor: 7.851

2.  C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes.

Authors:  Regina Tavano; Luca Gabrielli; Elisa Lubian; Chiara Fedeli; Silvia Visentin; Patrizia Polverino De Laureto; Giorgio Arrigoni; Alessandra Geffner-Smith; Fangfang Chen; Dmitri Simberg; Giulia Morgese; Edmondo M Benetti; Linping Wu; Seyed Moein Moghimi; Fabrizio Mancin; Emanuele Papini
Journal:  ACS Nano       Date:  2018-05-23       Impact factor: 15.881

Review 3.  Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung.

Authors:  Daiqin Chen; Jinhao Liu; Jerry Wu; Jung Soo Suk
Journal:  Expert Opin Drug Deliv       Date:  2020-12-07       Impact factor: 8.129

Review 4.  Optimizations of In Vitro Mucus and Cell Culture Models to Better Predict In Vivo Gene Transfer in Pathological Lung Respiratory Airways: Cystic Fibrosis as an Example.

Authors:  Rosy Ghanem; Véronique Laurent; Philippe Roquefort; Tanguy Haute; Sophie Ramel; Tony Le Gall; Thierry Aubry; Tristan Montier
Journal:  Pharmaceutics       Date:  2020-12-31       Impact factor: 6.321

Review 5.  Thiolated Nanoparticles for Biomedical Applications: Mimicking the Workhorses of Our Body.

Authors:  Nathalie Hock; Giuseppe Francesco Racaniello; Sam Aspinall; Nunzio Denora; Vitaliy V Khutoryanskiy; Andreas Bernkop-Schnürch
Journal:  Adv Sci (Weinh)       Date:  2021-11-12       Impact factor: 16.806

6.  Structure and characterisation of hydroxyethylcellulose-silica nanoparticles.

Authors:  Edward D H Mansfield; Yash Pandya; Ellina A Mun; Sarah E Rogers; Inbal Abutbul-Ionita; Dganit Danino; Adrian C Williams; Vitaliy V Khutoryanskiy
Journal:  RSC Adv       Date:  2018-02-08       Impact factor: 3.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.